These claims include assertions that Latinos who use Medicaid, the federal-state program for low-income people and those with disabilities, “do not work” and exaggerations of the percentage of people ...

Encouraging different perspectives will be central to Bhattacharya’s approach as part of his larger mission to restore public trust in science.

OriGen Health Research Center will examine variables affecting chronic illnesses in different Latino and Mexican populations.

“Tesla = AIDS”: The action marked the 38 th anniversary of ACT UP, the activist group whose lifesaving HIV triumphs are now threatened.

The Trump administration is set to dismantle the federal government’s Office of Long COVID Research and Practice (OLC) this week as part of a larger restructuring of health agencies, sources have told ...

Epstein-Barr virus (EBV) is a common virus that causes mononucleosis, or mono for short, and is associated with some types of cancer and autoimmune diseases. Despite EBV’s known effects and potential ...

Long-acting treatment with injectable cabotegravir and rilpivirine (Cabenuva) may be an option for people who are unable to maintain an undetectable viral load on oral antiretroviral treatment, ...

During one of the most active flu seasons in recent memory, infectious disease experts at Fred Hutch Cancer Center say many of the public health lessons learned during the COVID-19 epidemic still ...

A custom-made messenger RNA (mRNA) vaccine plus an immune checkpoint inhibitor appears to reduce the risk of pancreatic cancer recurrence for at least three years after surgery, according to results ...

Recruiting and screening individuals for clinical trials is time-consuming and can account for to up to one third of trial costs. But researchers have found that artificial intelligence (AI) could ...

The House GOP Budget Plan Seeks $880 Billion in Cuts Medicaid serves about 1 in 5 Americans.The health care program for low-income people is paid for by the federal government and partly by states.

Twice-yearly lenacapavir pre-exposure prophylaxis (PrEP), which is expected to launch this summer, has been hailed as a major breakthrough, but once-yearly HIV prevention shots could have an even ...